Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
50.5M
-
Number of holders
-
132
-
Total 13F shares, excl. options
-
22.2M
-
Shares change
-
+276K
-
Total reported value, excl. options
-
$454M
-
Value change
-
+$5.83M
-
Number of buys
-
73
-
Number of sells
-
-52
-
Price
-
$20.43
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q1 2019
149 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q1 2019.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 132 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.2M shares
of 50.5M outstanding shares and own 44.01% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.84M shares), VANGUARD GROUP INC (2.32M shares), DIMENSIONAL FUND ADVISORS LP (1.92M shares), FEDERATED INVESTORS INC /PA/ (1.47M shares), STATE STREET CORP (1.06M shares), Invesco Ltd. (867K shares), TEACHERS ADVISORS, LLC (566K shares), NORTHERN TRUST CORP (474K shares), GEODE CAPITAL MANAGEMENT, LLC (445K shares), and RENAISSANCE TECHNOLOGIES LLC (442K shares).
This table shows the top 132 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.